Tomuzotuximab
Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects[1].
Product Specifications
CAS Number
[1646321-00-7]
Product Name Alternative
Anti-Human EGFR Recombinant Antibody; CetuxiMab-GEX, GEXMab52201
UNSPSC
12352203
Target
Apoptosis; EGFR
Type
Inhibitory Antibodies
Related Pathways
Apoptosis; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tomuzotuximab.html
Purity
99.93
Solubility
10 mM in DMSO
Smiles
[Tomuzotuximab]
Molecular Weight
(145.46 kDa)
References & Citations
[1]Waer Fiedler, et al. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas. ESMO Open. 2018 Feb 1;3 (2) :e000303.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
